Sohel S. Shaikh , Kuldip Vyas , Ayush Sharma , Snehal S. Patel , Farhana Malek , Anis Malik
{"title":"探索凝结芽孢杆菌BCP92™在调节抑郁样行为中的作用:揭示微生物组肠-脑轴。","authors":"Sohel S. Shaikh , Kuldip Vyas , Ayush Sharma , Snehal S. Patel , Farhana Malek , Anis Malik","doi":"10.1016/j.bbr.2025.115776","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Recent findings indicate that gut microbiota can significantly impact cognitive health. In this study, we explored the effects of <em>Bacillus coagulans (Heyndrickxia coagulans)</em> BCP92™ on depression-like behaviors using maternal separation and the chronic unpredictable mild stress model.</div></div><div><h3>Methods</h3><div>Depression in rats was induced through maternal separation followed by chronic unpredictable mild stress. <em>B. coagulans</em> BCP92™ was administered to the rats at a dose of 2 billion CFU for six weeks. Depression-like behaviors were assessed using the sucrose preference test, forced swim test, elevated plus maze test, and open-field test. After the treatment period, the animals were sacrificed, and brain, intestine, and fecal samples were collected for biochemical, molecular, and histopathological analyses.</div></div><div><h3>Results</h3><div><em>B coagulans</em> BCP92™ mitigated depressive behaviors as evidenced by improvements in the behavior assessments. The treatment related changes in levels of neurotransmitters such as noradrenaline, dopamine, serotonin, and brain-derived neurotrophic factor while reducing pro-inflammatory markers like C-reactive protein, TNF-α, and IL-1β in the brain. Additionally, <em>B. coagulans</em> BCP92™ administration restored levels of BDNF, doublecortin, GFAP, and zona occludens in the brain, suggesting a neuroprotective effect. An increased ratio of Firmicutes to Bacteroidetes, along with higher levels of short-chain fatty acids in fecal samples, was observed. Histopathological analysis indicated that both brain and intestinal structures were preserved, demonstrating the maintenance of their integrity.</div></div><div><h3>Conclusion</h3><div>The findings from this study suggest that <em>B. coagulans</em> BCP92™ exerts antidepressant effects by modulating the gut-brain axis, thereby remodeling gut microbiota and promoting neurobehavioral health.</div></div>","PeriodicalId":8823,"journal":{"name":"Behavioural Brain Research","volume":"495 ","pages":"Article 115776"},"PeriodicalIF":2.3000,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Exploring role of Bacillus coagulans BCP92™ (MTCC 25460) in modulation of depressive-like behavior: Unraveling microbiome gut-brain axis\",\"authors\":\"Sohel S. Shaikh , Kuldip Vyas , Ayush Sharma , Snehal S. Patel , Farhana Malek , Anis Malik\",\"doi\":\"10.1016/j.bbr.2025.115776\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Recent findings indicate that gut microbiota can significantly impact cognitive health. In this study, we explored the effects of <em>Bacillus coagulans (Heyndrickxia coagulans)</em> BCP92™ on depression-like behaviors using maternal separation and the chronic unpredictable mild stress model.</div></div><div><h3>Methods</h3><div>Depression in rats was induced through maternal separation followed by chronic unpredictable mild stress. <em>B. coagulans</em> BCP92™ was administered to the rats at a dose of 2 billion CFU for six weeks. Depression-like behaviors were assessed using the sucrose preference test, forced swim test, elevated plus maze test, and open-field test. After the treatment period, the animals were sacrificed, and brain, intestine, and fecal samples were collected for biochemical, molecular, and histopathological analyses.</div></div><div><h3>Results</h3><div><em>B coagulans</em> BCP92™ mitigated depressive behaviors as evidenced by improvements in the behavior assessments. The treatment related changes in levels of neurotransmitters such as noradrenaline, dopamine, serotonin, and brain-derived neurotrophic factor while reducing pro-inflammatory markers like C-reactive protein, TNF-α, and IL-1β in the brain. Additionally, <em>B. coagulans</em> BCP92™ administration restored levels of BDNF, doublecortin, GFAP, and zona occludens in the brain, suggesting a neuroprotective effect. An increased ratio of Firmicutes to Bacteroidetes, along with higher levels of short-chain fatty acids in fecal samples, was observed. Histopathological analysis indicated that both brain and intestinal structures were preserved, demonstrating the maintenance of their integrity.</div></div><div><h3>Conclusion</h3><div>The findings from this study suggest that <em>B. coagulans</em> BCP92™ exerts antidepressant effects by modulating the gut-brain axis, thereby remodeling gut microbiota and promoting neurobehavioral health.</div></div>\",\"PeriodicalId\":8823,\"journal\":{\"name\":\"Behavioural Brain Research\",\"volume\":\"495 \",\"pages\":\"Article 115776\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-08-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Behavioural Brain Research\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0166432825003638\",\"RegionNum\":3,\"RegionCategory\":\"心理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BEHAVIORAL SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behavioural Brain Research","FirstCategoryId":"102","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0166432825003638","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
Exploring role of Bacillus coagulans BCP92™ (MTCC 25460) in modulation of depressive-like behavior: Unraveling microbiome gut-brain axis
Background
Recent findings indicate that gut microbiota can significantly impact cognitive health. In this study, we explored the effects of Bacillus coagulans (Heyndrickxia coagulans) BCP92™ on depression-like behaviors using maternal separation and the chronic unpredictable mild stress model.
Methods
Depression in rats was induced through maternal separation followed by chronic unpredictable mild stress. B. coagulans BCP92™ was administered to the rats at a dose of 2 billion CFU for six weeks. Depression-like behaviors were assessed using the sucrose preference test, forced swim test, elevated plus maze test, and open-field test. After the treatment period, the animals were sacrificed, and brain, intestine, and fecal samples were collected for biochemical, molecular, and histopathological analyses.
Results
B coagulans BCP92™ mitigated depressive behaviors as evidenced by improvements in the behavior assessments. The treatment related changes in levels of neurotransmitters such as noradrenaline, dopamine, serotonin, and brain-derived neurotrophic factor while reducing pro-inflammatory markers like C-reactive protein, TNF-α, and IL-1β in the brain. Additionally, B. coagulans BCP92™ administration restored levels of BDNF, doublecortin, GFAP, and zona occludens in the brain, suggesting a neuroprotective effect. An increased ratio of Firmicutes to Bacteroidetes, along with higher levels of short-chain fatty acids in fecal samples, was observed. Histopathological analysis indicated that both brain and intestinal structures were preserved, demonstrating the maintenance of their integrity.
Conclusion
The findings from this study suggest that B. coagulans BCP92™ exerts antidepressant effects by modulating the gut-brain axis, thereby remodeling gut microbiota and promoting neurobehavioral health.
期刊介绍:
Behavioural Brain Research is an international, interdisciplinary journal dedicated to the publication of articles in the field of behavioural neuroscience, broadly defined. Contributions from the entire range of disciplines that comprise the neurosciences, behavioural sciences or cognitive sciences are appropriate, as long as the goal is to delineate the neural mechanisms underlying behaviour. Thus, studies may range from neurophysiological, neuroanatomical, neurochemical or neuropharmacological analysis of brain-behaviour relations, including the use of molecular genetic or behavioural genetic approaches, to studies that involve the use of brain imaging techniques, to neuroethological studies. Reports of original research, of major methodological advances, or of novel conceptual approaches are all encouraged. The journal will also consider critical reviews on selected topics.